In line with this notion, we found that cancer cells (B16F10 and LLC) proliferated at the same rate in both Smad3+/+ and Smad3−/− mice during the first week after tumour implantation, but the progression was dramatically inhibited in the Smad3−/− mice from week 2 onwards. Here, SMAD3 is linked to cancer.